CRDF FY 2014 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$137M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$280,000+8.0% YoY

Gross Profit

$265,00094.6% margin

Operating Income

-$15M-5337.5% margin

Net Income

-$14M-5116.1% margin

EPS (Diluted)

$-54.08

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$29M

Total Liabilities

$21M

Stockholders' Equity

$8M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$280,000	$259,246	+8.0%
Gross Profit	$265,000	-$3M	+108.2%
Operating Income	-$15M	-$11M	-39.8%
Net Income	-$14M	-$12M	-21.3%